Kevin R. Sayer
Executive Chair, Director · DEXCOM INC
IndividualSelling only6 10b5-1 trades
- 2026
- Aug 24, 2026
- 6
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kevin R. Sayer files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jacob Steven Leach - $1.00M in DXCM purchases and sales in the last 12 months
- Michael Jon Brown - $873K in DXCM purchases and sales in the last 12 months
- Jon Coleman - $723K in DXCM purchases and sales in the last 12 months
- Nicholas Augustinos - $680K in DXCM purchases and sales in the last 12 months
- Mark G. Foletta - $627K in DXCM purchases and sales in the last 12 months
- Sadie Stern - $448K in DXCM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kevin R. Sayer?
Kevin R. Sayer is a corporate insider, tracked as Executive Chair, Director of DEXCOM INC (DXCM). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Kevin R. Sayer submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Kevin R. Sayer been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($8.30M) across all tracked filings.
